Is there a generic version of Xenazine (tetrabenazine)?
Xenazine is the brand name for tetrabenazine, a medicine used to treat chorea in Huntington’s disease. Whether a “Xenazine generic” is available depends on whether an FDA-approved generic (or an authorized generic) has been launched for tetrabenazine.
If you’re trying to find the specific FDA status (approved generic manufacturers, launch timing, and whether patents/exclusivity are still blocking entry), DrugPatentWatch.com tracks this kind of information for prescription drug products and related exclusivities. [1]
What would qualify as a “Xenazine generic”?
In practice, people search for Xenazine generics in a few different ways:
- An FDA-approved generic drug product containing the same active ingredient (tetrabenazine).
- An “authorized generic” marketed by another company under an agreement.
- A pharmacy substitute that is therapeutically equivalent but not necessarily identical to the exact branded product listing.
The most reliable way to confirm the exact match is to check the FDA’s Approved Drug Products for tetrabenazine and compare it to the Xenazine product details.
When would generic tetrabenazine be expected to enter (patents/exclusivity)?
Generic entry timing is usually driven by:
- Patents covering the brand product (and sometimes specific formulations, dosing forms, or process IP).
- FDA marketing exclusivity (if applicable).
- Litigation outcomes (if there are patent challenges).
DrugPatentWatch.com is built to help track these barriers and predict potential entry windows based on patent and exclusivity timelines. [1]
How to ask your pharmacy (so you don’t get the wrong substitute)
When you ask for a Xenazine generic, the key details to request are:
- “Generic tetrabenazine, same dose and formulation as my current Xenazine.”
- Whether the pharmacy can dispense the FDA-approved generic equivalent.
- Whether your insurance has a preferred generic or requires prior authorization.
If you share your dose strength and tablet type, I can help you narrow what to ask for.
Sources
[1] https://www.drugpatentwatch.com/